Evaluation: Plasma Protein Therapeutics Association | Keeping Plasma and Patients Safe
Evaluation | Part 3
Evaluation | Transcultural Competence: Much More Than You Think
Beyond Infection: The Realities of Primary Immunodeficiency. A CE Supplement. – Evaluation
Part 6. Secondary Immune Deficiencies from Biological Agents – Evaluation
Part 5. Immune Dysregulation – Evaluation
Part 4. Pulmonary Complications of Primary Immunodeficiency – Evaluation
Part 3. The Complex Primary Immunodeficient Patient – Evaluation
Part 2. Autoinflammatory Disorders – Evaluation
Part 1. Primary Immunodeficiency: An Overview – Evaluation
Questions for Pulmonary Complications of Primary Immunodeficiency | 2023
Evaluation for Primary Immune Deficiency in Geriatric Patients | 2023
Questions for Secondary Immune Deficiencies from Biological Agents | 2023
Questions for Immune Dysregulation | 2023
Questions for the Complex PI Patient | 2023
Post questions for Autoinflammatory Disorders | 2023
Evaluation for Plasma Protein Therapeutics Association: Keeping Plasma and Patients Safe | 2023
Evaluation for Needle Phobia, Pain, Anxiety, and Therapy Avoidance | 2023
Evaluation for The Intersection of Immune Deficiency and Autoimmunity | 2023
Evaluation for IVIg in the Treatment of Autoimmune Blistering Diseases | 2023
Evaluation for Ig Treatment Planning | 2023
Evaluation for Ig Therapy for Antibody Mediated Diseases | 2023
Evaluation for Building a Culture of Safety: No Heroes Allowed | 2023
Evaluation for Multi-therapy Approaches to Management of Myasthenia Gravis | 2023
Questions for Clinical Updates in the Management of CIDP | 2023
Questions for Exploring Novel Approaches to Treatment of Myasthenia Gravis | 2023
Evaluations | Beyond Infection Supplement
Manuscript Evaluations Copy
Manuscript Evaluations Copy
Manuscript Evaluations Copy
Foundational Review Evaluation
Certification Review Evaluation
IgCN Certification Review Evaluation
Master Session Evaluation Template
Questions for Clinical Updates in the Management of CIDP
Manuscript Evaluations (Copy)
Questions for Exploring Novel Approaches to Treatment of Myasthenia Gravis
Manuscript Evaluations
Evaluation for Difficult Cases in Neuromuscular Disorders
Evaluation
Evaluation for Difficult Cases in Primary Immunodeficiency: Grand Rounds
Evaluation for Administration of Ig: Using the IgNS Standards to Guide Your Practice
Evaluation for the Anatomy of an Ig Script
Evaluation
Evaluation for Clinical Uses of Ig Therapy
Evaluation
Evaluation for Product Overview and Manufacturing Process
Evaluation
Questions for Autoinflammatory Disorder
Evaluation
Questions for Secondary Immune Deficiencies from Biological Agents
Questions for Immune Dysregulation
Questions for Pulmonary Complications of Primary Immunodeficiency
Questions for the Complex PI Patient
Post questions for Autoinflammatory Disorders
Post-Test
Post-Test
Speaker:
Tuan H. Vu, MD
Continuing Education:
Nursing 1 contact hour
ACPE 1 contact hour
AAFP 1 contact hour
Recertification:
1 IgCN® / IgCP® Recertification Units
Post-Test
Post-test
Post-Test
Post-Test
Post-Test
Post-Test
Post-test
Post-Test
Post-Test
Transcultural Competence: Much More Than You Think – Evaluation
Post-Test
Post-Test
Evaluation for Session 1
test
Post Test
Post-test
Post Test
Post Test
Session Evaluation
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Evaluation
Evaluation
Post Test
Ig Certified Nurse Recertification Application
Post Test
Test Quiz
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Post Test
Costs Associated with the Treatment of Ig Adverse Drug Reactions
Post Test